Doximity Inc (DOCS) Stock Analysis

Verdict: WATCH (do not buy)

AI-driven engagement is revitalizing growth, but massive insider selling and institutional downgrades suggest the recent 31% pop is overextended.

Investment score: 58/100

Analysis as of 2026-08-10

Is Doximity Inc stock worth reviewing? AI model thesis

Doximity is a high-margin platform business currently undergoing a re-rating based on its AI integration. However, the technical extension and insider selling warrant caution.

7-factor investment score

Valuation: 52/100 (weight 20%)
Financial Health: 85/100 (weight 15%)
Technical Momentum: 70/100 (weight 15%)
Earnings Quality: 45/100 (weight 15%)
Insider Sentiment: 20/100 (weight 10%)
Analyst Consensus: 40/100 (weight 10%)
Risk-Adjusted Return: 55/100 (weight 15%)

Doximity Inc opportunities and risks

What speaks for DOCS

AI Search Monetization

What speaks against DOCS

Institutional Distribution Trend

Peers and competitors

Trailing-twelve-month ratios
Ticker	P/E	P/S	EV/EBITDA	Gross margin	Net margin	FCF yield
DOCS	30.8x	7.8x	19.9x	88.1%	25.5%	5.8%
VEEV	40.0x	11.3x	27.4x	75.0%	28.4%	4.4%
WAY	33.7x	3.9x	14.1x	69.1%	11.2%	5.3%
HTFL	n/a	13.0x	n/a	78.1%	-58.4%	-3.1%
SDGR	n/a	5.2x	n/a	56.9%	-21.0%	-3.7%
TDOC	n/a	0.5x	n/a	73.5%	-7.1%	17.3%
Peer median	n/a	5.2x	n/a	73.5%	-7.1%	4.4%

Frequently asked questions about Doximity Inc (DOCS)

Is DOCS stock a good investment?

The cached TradeMates AI model rates Doximity Inc as WATCH (do not buy) with an investment score of 58/100. Doximity is a high-margin platform business currently undergoing a re-rating based on its AI integration. However, the technical extension and insider selling warrant caution. This is algorithmic model output, not personal investment advice.

Is DOCS stock a buy?

The TradeMates model verdict for DOCS is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.